Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Critical RiskFDA Drug
Medications & Supplements/Over-the-Counter

Healthy Living Migraine Relief Recalled for Missing Drug Facts Label

Agency Publication Date: August 20, 2024
Share:
Sign in to monitor this recall

Summary

Aurobindo Pharma USA Inc is recalling 240 bottles of Healthy Living Migraine Relief (Acetaminophen, Aspirin, and Caffeine) tablets in 100-count bottles. Some bottles are missing the manufacturer's label, which contains the Drug Facts, safety warnings, and dosage instructions. This recall affects product from lot number AC2523005A with an expiration date of June 30, 2025. Without this critical labeling, consumers may use the product incorrectly or miss important warnings regarding allergies or drug interactions.

Risk

Missing label information prevents consumers from seeing critical Drug Facts, including proper dosage, safety warnings, and ingredient lists. This poses a significant health risk as users may inadvertently exceed safe dosages or consume the medication despite having an allergy or medical contraindication.

What You Should Do

  1. This recall affects 100-count bottles of Healthy Living Migraine Relief (Acetaminophen, Aspirin, and Caffeine) tablets (NDC 58602-882-21) with lot number AC2523005A and an expiration date of June 30, 2025.
  2. If you have health concerns about having used this product without the required safety labeling, contact your healthcare provider or pharmacist.
  3. Return any unused product to the place of purchase for a refund, throw it away, or contact Aurobindo Pharma USA Inc for further instructions.
  4. Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls for additional information.

Your Remedy Options

You have 2 options:

💰Option 1: Full Refund
How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund
🗑️Option 2: Dispose of Product
How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Healthy Living Migraine Relief (Acetaminophen, Aspirin, and Caffeine) tablets USP
Variants: 250 mg/250 mg/65 mg, 100-count bottles
Lot Numbers:
AC2523005A (Exp 6/30/2025)
NDC:
58602-882-21

Some bottles are missing the manufacturers label that includes drug facts information. Label identifier X003WQ6HF7 may appear on packaging.

Product Images

Amazon product label, Healthy Living Migraine Relief Acetaminophen, Aspirin (NSAID) & Caffeine Tablets

Amazon product label, Healthy Living Migraine Relief Acetaminophen, Aspirin (NSAID) & Caffeine Tablets

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 94966
Status: Active
Manufacturer: Aurobindo Pharma USA Inc
Sold By: Aurohealth LLC
Manufactured In: India
Units Affected: 240 bottles
Distributed To: New Jersey, New York, Pennsylvania

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · FDA Press Release · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.